Itipharma Ghyselen SRL
Itipharma Ghyselen reported total assets of 61,934 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jul 2026).
The score of Itipharma Ghyselen shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Itipharma Ghyselen's annual accounts
| 2025 | |
|---|---|
| Net result | 33,287 € |
| Equity | 36,287 € |
| Cash | 47,464 € |
| EBITDA | 41,848 € |
| Total assets | 61,934 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jul 2026
Itipharma Ghyselen's financial analysis
- Solvency58.6%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Itipharma Ghyselen
Itipharma Ghyselen's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1028.767.449
- VAT number
- BE1028767449
- Peppol
- Registered · 0208:1028767449 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Oct 2025
- Registered office
- 7060 Soignies
- Latest accounts
- 2025 · filed on 10 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Itipharma Ghyselen (SRL) has been based in Soignies since 2025, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 33,287 € and equity of 36,287 €; its revenue is not published. Its solvency stands at 58.6%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Itipharma Ghyselen
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- MGS Pharma Retail sale of pharmaceutical products Stavelot · balance sheet 68,803 €
- Helephar Retail sale of pharmaceutical products Wingene · balance sheet 55,332 €
- Tilosa Retail sale of pharmaceutical products Lokeren · balance sheet 70,195 €
- Vanfleteren Pieter Retail sale of pharmaceutical products Antwerp · balance sheet 52,894 €
- NT Farma Retail sale of pharmaceutical products Mouscron · balance sheet 56,255 €
- Siga Pharm Retail sale of pharmaceutical products Uccle · balance sheet 46,193 €
- Van Aelst Leonie Retail sale of pharmaceutical products Beernem · balance sheet 86,688 €
Frequently asked questions about Itipharma Ghyselen
What is the revenue of Itipharma Ghyselen?
Itipharma Ghyselen files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Itipharma Ghyselen?
In Belgium, the VAT number is the company number prefixed with BE: BE1028767449 for Itipharma Ghyselen, if the company is VAT-registered. Its company number (CBE) is 1028.767.449.
Where is the registered office of Itipharma Ghyselen?
According to the CBE register, the registered office of Itipharma Ghyselen is in 7060 Soignies.
What is the equity of Itipharma Ghyselen?
At the close of the 2025 financial year, the equity of Itipharma Ghyselen amounts to 36,287 €, a solvency of 58.6% of total assets.
Who manages Itipharma Ghyselen?
The register lists 1 active mandates at Itipharma Ghyselen. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Itipharma Ghyselen
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →